In the case of the Ago hook in NRPD1b, how does an RNA polymerase-associated AGO4 protein affect transcription, transcript recognition, and siRNA-guided DNA methylation? Recent evidence suggests that NRPD1b may generate Pol IVb transcripts primed by an siRNA and may be involved in the siRNA-mediated targeting of heterochromatin . It is not clear how AGO4 modulates the functions of NRPD1b relative to those of NRPD1a, which may possess genuine DNA-or RNA-dependent RNA polymerase activity. The Tas3 Ago hook is necessary for the establishment rather than maintenance of Ago1-mediated centromeric silencing (Partridge et al., 2007) . Moreover, it is possible that Ago hooks have important functions beyond recruitment (Buhler et al., 2006) . In support of this hypothesis, Ago hooks bind to the PIWI domain of Ago proteins (Behm-Ansmant et al., 2006; Till et al., 2007) , a functionally critical domain that harbors siRNA-mediated "slicer" activity and recognizes the "seed" region in miRNAs. In fact, site-directed mutagenesis of human Ago2 PIWI domains and competition assays suggest that Ago hooks are reversibly bound by the same surface that normally recognizes the 5′ end of guide siRNAs or miRNAs (Till et al., 2007) . Consistent with binding to this critical region in PIWI domains, Ago hook peptides relieve translational repression mediated by an miRNA in Drosophila extracts. It is therefore possible that the unusual CTD of NRPD1b not only mediates recruitment of AGO4 to the polymerase but also helps to regulate AGO4 function, for example by binding to it in a reversible manner, perhaps switching its ability to "slice" an RNA target into a homing function for DNA target regions. The El-Shami et al. study clearly shows that in plants RNA Pol IVb complexes use an Ago hook for AGO4-dependent DNA methylation in vivo. Future work will address how the fine-tuning of the dynamic interactions between AGO4 and Pol IVb determines the specialized transcription and RNAi processes that are required to silence the plant genome.
Gene expression in eukaryotes requires the removal of noncoding intervening intron sequences by the spliceosome to form the mature mRNA. There are two distinct spliceosome complexes. The major spliceosome comprises five small nuclear ribonucleoprotein particles (snRNPs), U1, U2, U4, U5, and U6, and a multitude of non-snRNP splicing factors (Jurica and Moore, 2003 There are two molecular machineries for pre-mRNA splicing-the major spliceosome and the minor spliceosome. In this issue of Cell, König et al. (2007) demonstrate that the two splicing pathways are spatially separated in the cell and may have distinct functions.
that mediates the excision of a minor class of introns harboring noncanonical consensus sequences has been discovered (Patel and Steitz, 2003; Will and Luhrmann, 2005) . This spliceosome, referred to as the minor spliceosome, comprises four unique snRNPs, U11, U12, U4atac, and U6atac, as well as the U5 snRNP, which is shared with the major spliceosome (Hall and Padgett, 1996; Tarn and Steitz, 1996) . Since its discovery, the physiological significance of the minor splicing pathway has been a mystery. In this issue, König et al. (2007) now show that the two pathways are spatially segregated in the cell and may act on distinct sets of genes ( Figure 1 ).
The first dramatic indication of fundamental differences between the two splicing pathways became clear when König et al. looked at the cellular localization of spliceosome components. In situ hybridization on tissue sections from adult zebrafish revealed perinuclear and cytoplasmic staining for the minor spliceosome components U12 and U6atac, compared to the well-established nuclear distribution of the U2 snRNA of the major spliceosome. A similar localization pattern was found in mammalian cultured cells, establishing that differential cellular localization of major-and minor-class snRNAs is a conserved feature in vertebrates.
Three lines of evidence suggest that the cytoplasmic pool of U12 and U6atac is functionally active. First, transcripts with unspliced minor introns are found in the cytoplasm. Second, selective inhibition of minor-class splicing in the cytoplasm-elegantly achieved using an U6atac antisense morpholino conjugated to a nuclear-export sequence-results in accumulation of unspliced U12-type introns in the cytoplasm. Finally, the minor spliceosome, unlike its major counterpart, is active during mitosis. These results extend recent findings of U2-dependent splicing in the cytoplasm of platelets and dendritic cells (Denis et al., 2005; Glanzer et al., 2005) , which might have represented a peculiarity of those systems, thereby making a more general case for the existence of splicing in the cytoplasm.
The differential localization of major and minor splicing components allowed for the tantalizing possibility that they exert distinct cellular roles. To address this, König et al. investigated the function of the minor spliceosome at the organismal level in developing zebrafish embryos. Upon specific inhibition of the major or minor spliceosome using antisense morpholinos to U2 or U12 (U6atac) snRNAs, respectively, they found distinct requirements for the two spliceosomes in development. Interference with U2-mediated splicing caused early developmental arrest, whereas interference with the minor spliceosome had an effect later in development. The observed phenotypes after inhibition of U12-mediated splicing pointed to a role of minor-class splicing in cell proliferation and indeed interference with minor spliceosome function blocks cellcycle progression in zebrafish and in mammalian cells. Consistent with this notion, downregulation of U11/U12-specific proteins in HeLa cells is known to affect cell viability (Will et al., 2004) .
These results suggest a division of labor between the two spliceosomes (Figure 1) . The full functional and physiological relevance of cytoplasmic splicing is, however, not entirely clear. For example, it appears that some minor splicing does occur in the nucleus and it is not known whether all or only a specific subset of U12-type-containing RNAs are spliced in the cytoplasm. Furthermore, it has not been shown formally that a lack of cytoplasmic U12 splicing activity is responsible for the developmental defects in zebrafish embryos; nuclear minor splicing also may contribute.
What is the advantage of sequestering the two splicing pathways in different cellular locations? It cannot be excluded that minor splicing in the cytoplasm simply occurs by default on any U12-type intron-containing RNA. However, it is possible that, just as for cytoplasmic U2 splicing in platelets, U12 splicing in the cytoplasm is a tightly regulated process representing an additional layer of gene regulation for U12-intron-containing transcripts. Circumstantial support for this possibility comes from the fact that both types of known cytoplasmically spliced RNAs-signaling components in platelets and proliferation factors that act during late embryonic development-are temporally tightly regulated in their respective cell types. Identification of the full complement of cytoplasmically spliced transcripts in various physiological situations should provide insights into the functional relevance of cytoplasmic splicing in gene regulation. Subcellular localization and function of major and minor pre-mRNA splicing pathways. The major splicing pathway removes U2-type introns allowing the adjacent exons (blue) to be spliced together in the nucleus before export of the fully spliced transcripts to the cytoplasm. Transcripts that also contain U12-type introns are exported as partially spliced transcripts and their exons (orange) are spliced together by the U12 pathway in the cytoplasm. The mechanism by which they evade RNA surveillance in the nucleus is unknown. Although U2-type introns are found globally, results from König et al. (2007) suggest that U12-type introns may occur preferentially in particular sets of genes such as those involved in cellular proliferation.
An interesting implication from this work is the issue of how mRNAs that harbor unspliced U12-type introns escape from the nucleus (Figure 1) . Normally, incompletely spliced RNAs are retained in the nucleus until they are fully processed or they are targeted for degradation. The fate of a newly spliced RNA is typically determined by the deposition of the exon-junction complex (EJC), which assembles over newly joined exons immediately after splicing and promotes export of correctly spliced RNA. It is possible that the presence of the EJC on multiple spliced U2-type exons in U12-containing RNAs is sufficient to mark it for export. On the other hand, specific factors might exist that recognize the partially spliced U12-type RNAs, prevent their degradation, and facilitate their nuclear export. Interestingly, this situation is akin to the fate of mRNAs that retain intronic sequences as part of their normal alternative splicing but are nevertheless exported.
The results reported by König et al. might also have implications for how we think about the evolution of splicing. The minor spliceosome has an early evolutionary origin (Russell et al., 2006) . U2-type splice junctions are far more degenerate than U12-type junctions, suggesting that U12-exons were at one point dominant and U2-exons evolutionarily derived from them. Although provocative, it raises the question of whether more, or even all, pre-mRNA splicing at one point in time occurred in the cytoplasm. The correct expression of the more complex genes and genomes of higher organisms might have required closer coordination of pre-mRNA splicing and quality control with transcription, therefore favoring migration of the splicing reaction to the cell nucleus. Thus, the discovery of splicing in the cytoplasm provides a glimpse into the distant past, while also opening up a new vista on the future of pre-mRNA splicing.
Lysosomes are acidic intracellular organelles where many proteins, lipids, and other macromolecules are delivered for degradation by lysosomal acid hydrolases. Ever since the discovery of lysosomes by de Duve and colleagues (de Duve et al., 1955), much of our understanding of how proteins are trafficked to this compartment and how they function has come from studies on a wide range of lysosomal storage diseases. In this family of genetic diseases, defects in the function of the lysosome results in mis-sorting or loss of function of lysosomal proteins with deleterious consequences. In the case of the lysosomal storage disease Inclusion-cell (I-cell) disease, lysosomal dysfunction is caused by secretion of most lysosomal enzymes from the cell. Most lysosomal proteins are tagged with a carbohydrate modification that allows their recognition and transport to the lysosome. In this issue, Reczek et al. (2007) identify a new pathway for protein sorting to the lysosome. They show that β-glucocerebrosidase-the lysosomal enzyme defective in patients with Gaucher disease-is delivered to the lysosome through its interaction with the transmembrane protein LIMP-2.
